Suppr超能文献

低氧诱导的干/祖细胞迁移介质在血管瘤患儿中增加。

Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma.

作者信息

Kleinman Mark E, Greives Matthew R, Churgin Samara S, Blechman Keith M, Chang Eric I, Ceradini Daniel J, Tepper Oren M, Gurtner Geoffrey C

机构信息

Stanford University, Department of Surgery, PSRL, GK-201, 257 Campus Drive West, Stanford, CA, 94305-5148, USA.

出版信息

Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2664-70. doi: 10.1161/ATVBAHA.107.150284. Epub 2007 Sep 13.

Abstract

OBJECTIVE

The mechanism of neovascularization during the proliferative phase of infantile hemangioma is poorly understood. It is known that circulating bone marrow-derived endothelial progenitor cells (EPCs) form new blood vessels in ischemic tissues using mediators regulated by the transcription factor, HIF-1alpha. Mobilization of EPCs is enhanced by VEGF-A, matrix metalloproteinase (MMP)-9, and estrogen, whereas homing is secondary to localized expression of stromal cell-derived factor-1alpha (SDF-1alpha). We examined whether these mediators of EPC trafficking are upregulated during the proliferation of infantile hemangioma.

METHODS AND RESULTS

Surgical specimens and blood samples were obtained from children with proliferating hemangioma and age-matched controls (n=10, each group). VEGF-A and MMP-9 levels were measured in blood, and tissue sections were analyzed for SDF-1alpha, MMP-9, VEGF-A, and HIF-1alpha. The role of estrogen as a modulator of hemangioma endothelial cell growth was also investigated. We found that all these mediators of EPC trafficking are elevated in blood and specimens from children with proliferating infantile hemangioma. In vitro, the combination of hypoxia and estrogen demonstrated a synergistic effect on hemangioma endothelial cell proliferation.

CONCLUSIONS

These findings demonstrate that proliferating hemangiomas express known mediators of vasculogenesis and suggest that this process may play a role in the initiation or progression of this disease.

摘要

目的

婴儿血管瘤增殖期新生血管形成的机制尚不清楚。已知循环中的骨髓源性内皮祖细胞(EPCs)利用受转录因子HIF-1α调控的介质在缺血组织中形成新血管。血管内皮生长因子A(VEGF-A)、基质金属蛋白酶(MMP)-9和雌激素可增强EPCs的动员,而其归巢则继发于基质细胞衍生因子-1α(SDF-1α)的局部表达。我们研究了这些EPCs转运介质在婴儿血管瘤增殖过程中是否上调。

方法与结果

从增殖期血管瘤患儿和年龄匹配的对照组(每组n = 10)获取手术标本和血样。检测血中VEGF-A和MMP-9水平,并分析组织切片中的SDF-1α、MMP-9、VEGF-A和HIF-1α。还研究了雌激素作为血管瘤内皮细胞生长调节剂的作用。我们发现,在增殖期婴儿血管瘤患儿的血液和标本中,所有这些EPCs转运介质均升高。在体外,缺氧和雌激素的联合作用对血管瘤内皮细胞增殖具有协同效应。

结论

这些发现表明,增殖期血管瘤表达已知的血管生成介质,并提示这一过程可能在该疾病的起始或进展中起作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验